Treatment FAQ

who malaria treatment for resistance

by Robb Wintheiser Published 2 years ago Updated 2 years ago
image

To leverage on parasite resistance, cost of treatment, and burden of malaria infection to communities and governments, the WHO recommends the use of artemisinin-based combination therapies (ACTs) as the first- and second-line treatment drugs for uncomplicated P. falciparum malaria [ 25 ].

Multidrug resistant malaria : Drugs recommended for use are mefloquine, halofantrine and quinine with tetracycline. A three day course of clindamycin with quinine has proved effective in areas of endemic disease but there is insufficient evidence of their effectiveness in non-immune individuals [18].

Full Answer

What is the best drug to prevent malaria?

What is the Best Drug To Prevent Malaria? There are mainly four medicines used for prophylaxis of malaria. These include chloroquine, mefloqine, doxycycline and a combination of atovone and proguanil. Most of these medications are also used in acute treatment of the disease.

What is a good anti malaria treatment?

Types of antimalarial medication

  • Atovaquone plus proguanil. Dosage – the adult dose is 1 adult-strength tablet a day. ...
  • Doxycycline (also known as Vibramycin-D) Dosage – the dose is 100mg daily as a tablet or capsule. ...
  • Mefloquine (also known as Lariam) Dosage – the adult dose is 1 tablet weekly. ...
  • Chloroquine and proguanil. ...

Can you survive malaria without treatment?

The symptoms of malaria can occur even up to a year after travelling in an area in which malaria is present. Prompt treatment for malaria is essential, as without treatment it can be fatal. This leaflet gives general information about malaria and its treatment.

image

How does malaria become drug resistant?

Resistance of malaria parasites arises from several factors, including overuse of antimalarial drugs for prophylaxis, inadequate or incomplete therapeutic treatments of active infections, a high level of parasite adaptability at the genetic and metabolic levels, and a massive proliferation rate that permits selected ...

Why is malaria in Africa resistant to standard drug treatment?

Some people in sub-Saharan Africa contract malaria at a young age and then live with parasites in their blood, which, researchers think, helps them to build an immune tolerance to those strains.

WHO recommended malaria prophylaxis?

Malaria ChemoprophylaxisDrugDosageAtovaquone/proguanil (Malarone)250/100 mg per day one to two days before travel through seven days after returnDoxycycline100 mg per day one to two days before travel through four weeks after returnMefloquine250 mg per week one week before travel through four weeks after return3 more rows•May 15, 2012

What drugs are malaria resistant to?

Since then, chloroquine resistance has spread to nearly all areas of the world where falciparum malaria is transmitted. P. falciparum has also developed resistance to nearly all of the other currently available antimalarial drugs, such as sulfadoxine/pyrimethamine, mefloquine, halofantrine, and quinine.

Is malaria resistant to chloroquine?

Conclusion. The prevalence of chloroquine resistance alleles among Plasmodium falciparum parasites have steadily declined since discontinuation of chloroquine use. However, Pfcrt K76T and Pfmdr-1 N86Y mutations still persist at moderate frequencies in most malaria affected countries.

Is malaria resistant to quinine?

Quinine resistance Over the years, malaria parasites have developed resistance to a number of commonly used anti-malarial drugs. However the development of resistance to quinine has been slow. Although its use started in the 17th century, resistance to quinine was first reported in 1910 [88].

Why is doxycycline used for malaria?

Doxycycline 100 mg daily has been shown to be highly effective as a blood schizonticidal agent, meaning that it kills the asexual, erythrocytic stages of the malaria parasite.

Which is the best anti malaria tablets?

Artesunate Is the Best Choice for the Severe and Complicated Malaria Therapy.

What is the best treatment for malaria?

The most common antimalarial drugs include:Chloroquine phosphate. Chloroquine is the preferred treatment for any parasite that is sensitive to the drug. ... Artemisinin-based combination therapies (ACTs). ACT is a combination of two or more drugs that work against the malaria parasite in different ways.

What is chloroquine resistance?

Resistance to chloroquine of malaria strains is known to be associated with a parasite protein named PfCRT, the mutated form of which is able to reduce chloroquine accumulation in the digestive vacuole of the pathogen.

Is Plasmodium resistant to rifampin?

Rifampicin is an antitubercular drug with potent anti-malarial activity against Plasmodium vivax in humans [21], Plasmodium chabaudi in rodents and chloroquine resistant P. falciparum in vitro[22]. Combination of rifampicin with isoniazid and co-trimoxazole was found to be effective in patients with P.

What blood type is resistant to malaria?

Therefore, blood group O only protects against severe, life-threatening malaria (Table 2) and not against uncomplicated clinical malaria with low or high parasite burdens.

What is artemisinin and how is it used for the treatment of malaria?

Isolated from the plant Artemisia annua , or sweet wormwood, artemisinin and its derivatives are powerful medicines known for their ability to swi...

What is the definition of “artemisinin partial resistance”?

Artemisinin partial resistance typically refers to a delay in the clearance of malaria parasites from the bloodstream following treatment with an A...

What is the state of partial artemisinin resistance around the world?

Clear evidence of selection and spread of parasites partially resistant to artemisinin has now been identified in 2 parts of the world: the Greater...

What is the current state of ACT failures around the world?

The efficacy of WHO-recommended ACTs is assessed through therapeutic efficacy studies (TES). Such studies done at regular intervals at the same sit...

How is WHO supporting countries in the Greater Mekong subregion tackle multidrug resistance?

In the Greater Mekong Subregion (GMS), the response to resistance has included improved monitoring of efficacy and resistance and pursuit of malari...

How is WHO responding to the emergence of partial artemisinin resistance in Africa?

The emergence of artemisinin partial resistance in Africa necessitates a response aiming to ensure that efficacious treatments remain available. An...

Who is funding these efforts?

The fight to eliminate malaria in the Greater Mekong subregion (GMS) is supported through generous contributions from a number of donors, including...

Which countries have been certified as malaria free?

Over the last two decades, 11 countries have been certified by the WHO Director-General as malaria-free: United Arab Emirates (2007), Morocco (2010), Turkmenistan (2010), Armenia (2011), Sri Lanka (2016), Kyrgyzstan (2016), Paraguay (2018), Uzbekistan (2018), Algeria (2019), Argentina (2019) and El Salvador (2021). The WHO Framework for malaria elimination (2017) provides a detailed set of tools and strategies for achieving and maintaining elimination. In January 2021, WHO published a new manual, Preparing for certification of malaria elimination, with extended guidance for countries that are approaching elimination or preparing for elimination certification.

What is the most vulnerable group to malaria?

Children aged under 5 years are the most vulnerable group affected by malaria; in 2019, they accounted for 67% (274 000) of all malaria deaths worldwide. The WHO African Region carries a disproportionately high share of the global malaria burden. In 2019, the region was home to 94% of malaria cases and deaths.

How many countries have mosquito resistance?

According to the latest World malaria report, 73 countries reported mosquito resistance to at least 1 of the 4 commonly-used insecticide classes in the period 2010-2019. In 28 countries, mosquito resistance was reported to all of the main insecticide classes.

Why is it important to monitor the efficacy of antimalarial drugs?

Protecting the efficacy of antimalarial medicines is critical to malaria control and elimination. Regular monitoring of drug efficacy is needed to inform treatment policies in malaria-endemic countries, and to ensure early detection of, and response to, drug resistance.

How many cases of malaria worldwide in 2019?

It is preventable and curable. In 2019, there were an estimated 229 million cases of malaria worldwide. The estimated number of malaria deaths stood at 409 000 in 2019.

What is the cause of malaria?

Malaria is caused by Plasmodium parasites. The parasites are spread to people through the bites of infected female Anopheles mosquitoes, called "malaria vectors.". There are 5 parasite species that cause malaria in humans, and 2 of these species – P. falciparum and P. vivax – pose the greatest threat.

How long does it take for malaria to show symptoms?

Malaria is an acute febrile illness. In a non-immune individual, symptoms usually appear 10–15 days after the infective mosquito bite. The first symptoms – fever, headache, and chills – may be mild and difficult to recognize as malaria.

What are the threats of malaria?

The development of resistance to drugs poses one of the greatest threats to malaria control and results in increased malaria morbidity and mortality. Resistance to currently available antimalarial drugs has been confirmed in only two of the four human malaria parasite species, Plasmodium falciparum and P. vivax. It is unknown if P. malariae or P. ovale has developed resistance to any antimalarial drugs. P. knowlesi, a zoonotic monkey malaria that infects humans in forest fringe areas of Southeast Asia, is fully susceptible to chloroquine and other currently used drugs.

Is P. falciparum resistant to all drugs?

P. falciparum has also developed resistance to nearly all of the other currently available antimalarial drugs, such as sulfadoxine/pyrimethamine, mefloquine, halofantrine, and quinine. Although resistance to these drugs tends to be much less widespread geographically, in some areas of the world, the impact of multi-drug resistant malaria can be extensive. Most recently, resistance to the artemisinin and non-artemisinin components of artemisinin-based combination therapy has emerged in parts of Southeast Asia, impacting the efficacy of this vital antimalarial class.

What is an in vitro test for malaria?

In vitro tests: In these tests, blood samples from malaria patients are cultured and if found to be viable, the malaria parasites are exposed to different concentrations of antimalarial drugs in the laboratory.

How is malaria drug level determined?

Drug levels: When individuals who are presumably taking malaria prophylaxis develop malaria, blood samples can be collected and analyzed for the presence of the drug. The drug is extracted from the blood and the concentration is determined by high-performance liquid chromatographic methods.

Which antimalarial drug is the broadest?

Artemesinin derivatives offer the broadest antimalarial action against the range of developmental stages, and the most rapid in vivoactivity (ter Kuile et al., 1993; White, 1997). These compounds (and, to a lesser extent, chloroquine) prevent ring stages from maturing, hastening their clearance, and preventing end-organ pathology that would otherwise occur if cytoadherence progressed unchecked (Chotivanich et al., 2000).

What is the purpose of antimalarial drugs?

In severe falciparum malaria, the stage at which an antimalarial drug acts is especially important since the ultimate goal of treatment is to halt parasite maturation to late-stage, cytoadherent parasites (i.e., mature schizonts that attach to endothelial cellslining small blood vessels), which are primarily responsible for life-threatening complications. The artemisinin derivatives are advantageous because they prevent parasites from maturing to these more pathological stages, whereas quinine and quinidine do not affect parasites until they have already cytoadhered. The antifols act even later in the cycle, and are not recommended for severe malaria (Yayon et al., 1983; ter Kuile et al., 1993). None of the drugs will prevent rupture of infected erythrocytes and reinvasion once a schizonthas formed. Young ring forms (i.e., early asexual parasites) also are relatively drug resistant, especially to quinine and pyrimethamine.

How does Emax differ from antimalarial?

Individual antimalarial drugs differ in their Emax(i.e., the proportion of total plasmodia killed per treatment); for example, artemisinins often yield a 10,000-fold reduction per asexual cycle, whereas antimalarial antibiotics such as tetracycline or clindamycin may only achieve a 10-fold parasite reduction per cycle. The lowest blood or plasma concentration of an antimalarial drug that results in Emax can be considered a “minimum parasiticidal concentration” (MPC). Parasite reduction appears to be a first-order process throughout (Day et al., 1996), which means that a fixed fraction of the infecting malaria parasite population is removed with each successive cycle as long as the MPC is exceeded.

What happens to plasmodia after infection?

At any time after the infection is established, the vast majority of plasmodia will be in some stage of asexual maturation leading to another round of multiplication within the patient's bloodstream. However, a few parasites will have transformed into sexual stages (gametocytes) that, once ingested by mosquitoes, can perpetuate the transmission cycle. Because each stage of the malarial life cycle exhibits distinct biochemical and other characteristics (i.e., it expresses different proteins or locates in different sites within the body), a drug may kill one stage but have little effect on another. In other words, in each life-cycle stage the parasite manifests unique biological properties that can offer a target for the action of one or more antimalarial drugs.

What are the symptoms of falciparum malaria?

Fever, sweating, and chills (or, in some cases, merely fever) triggered by the release of plasmodia into the bloodstream from mature blood schizonts, are the most common symptoms heralding the onset of a clinical case of uncomplicated falciparum malaria(see Chapter 6for a description of the evolution of clinical symptoms). Without treatment—or an active immune response primed by repeated previous malaria infections—the number of parasites will increase with every 2-day cycle of reproduction. A mature infection may involve up to 1012circulating plasmodia.

Is atovaquone an antimalarial?

Atovaquone is an antimalarial in its own class with a unique mode of action; combined with proguanil it is sold under the trade name Malarone®. Several antibacterial drugs (e.g., tetracycline, clindamycin) also have antiplasmodial activity, although in general their action is slow for malaria treatment (as opposed to prophylaxis); they are recommended only in combination with other antimalarial drugs. Drugs active against Plasmodiumfalciparumalso are active against the other three malaria species that affect humans—P. vivax, P. malariae,and P. ovale—with the exception of antifols, which work poorly against P. vivax.

Is amodiaquine better than chloroquine?

There are now few places in the world where chloroquine can be relied upon for falciparum malaria, and SP resistance is spreading rapidly—so recent information on drug susceptibility is required if these drugs are used. Amodiaquine is more effective than chloroquine against chloroquine-resistant P. falciparum,but highly amodiaquine-resistant parasites are prevalent in East Asia.

image

Disease Burden

Prevention

  • Over the last 2 decades, expanded access to WHO-recommended malaria prevention tools and strategies – including effective vector control and the use of preventive antimalarial drugs – has had a major impact in reducing the global burden of this disease.
See more on who.int

Case Management

  • Early diagnosis and treatment of malaria reduces disease, prevents deaths and contributes to reducing transmission. WHO recommends that all suspected cases of malaria be confirmed using parasite-based diagnostic testing(through either microscopy or a rapid diagnostic test). Diagnostic testing enables health providers to swiftly distinguish between malarial and non-mal…
See more on who.int

Elimination

  • Malaria elimination is defined as the interruption of local transmission of a specified malaria parasite species in a defined geographical area as a result of deliberate activities. Continued measures to prevent re-establishment of transmission are required. In 2020, 26 countries reported fewer than 100 indigenous cases of the disease, up from 6 countries in 2000. Countries that hav…
See more on who.int

Surveillance

  • Malaria surveillance is the continuous and systematic collection, analysis and interpretation of malaria-related data, and the use of that data in the planning, implementation and evaluation of public health practice. Improved surveillance of malaria cases and deaths helps ministries of health determine which areas or population groups are most affected and enables countries to …
See more on who.int

Who Response

  • The WHO Global technical strategy for malaria 2016–2030, updated in 2021, provides a technical framework for all malaria-endemic countries. It is intended to guide and support regional and country programmes as they work towards malaria control and elimination. The strategy sets ambitious but achievable global targets, including: 1. reducing malari...
See more on who.int

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9